Corbus Pharmaceuticals Holdings (CRBP) Return on Sales (2015 - 2022)

Corbus Pharmaceuticals Holdings' Return on Sales history runs 8 years deep, the most recent figure standing at 4.6% for Q2 2022.

• In Q2 2022, Return on Sales fell 337.0% year-over-year to 4.6%; the TTM figure through Jun 2022 stood at 4.6% (down 436.0% YoY), while the FY2021 annual figure was 0.64%, down 39.0% from the prior year.
• Return on Sales was 4.6% for Q2 2022 at Corbus Pharmaceuticals Holdings, down from 2.1% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2019 to a low of 4.6% in Q2 2022.
• Historically, Return on Sales has averaged 0.76% across 5 years, with a median of 0.2% in 2021.
• The sharpest annual moves came in 2019 and 2022: Return on Sales surged 87 bps in 2019, then tumbled 337 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.86% in 2018, then soared by 101 bps to 0.01% in 2019, then plunged by 1378 bps to 0.12% in 2020, then sank by 425 bps to 0.64% in 2021, then sank by 624 bps to 4.6% in 2022.
• The last three Return on Sales figures came in at 4.6% (Q2 2022), 2.1% (Q1 2022), and 0.64% (Q4 2021), per Business Quant data.